**Morphologic interpretation:** The peripheral blood smear demonstrates a high proportion of blasts, including myeloblasts and lymphoblasts, with prominent nuclear features and variable cytoplasmic basophilia and vacuoles. The presence of multiple blast types, along with a blast percentage exceeding 50%, is consistent with acute myeloid leukemia (AML) morphology.

**Diagnostic flags:** blasts_present; blast_threshold_met

**Impression:** AML

**Differential considerations:**
- Lymphoblasts are present in significant numbers, which may suggest a lymphoid lineage involvement, but the predominance of myeloblasts and overall blast percentage supports AML.
- Monocytes and eosinophils are present in low numbers, which is consistent with AML but not typical of lymphoid malignancies.
- The presence of basophilic cytoplasm and vacuoles in some blasts may suggest a myeloid lineage with variable maturation, but does not override the overall AML classification.

**Recommended workup:**
- Perform flow cytometry to confirm lineage and identify potential immunophenotypic markers.
- Obtain bone marrow biopsy and aspirate for morphologic and cytogenetic analysis.
- Consider molecular testing for mutations such as FLT3, NPM1, and TP53, which are relevant in AML classification and prognosis.

## Quantitative Cell Summary

- Fields of view: 44
- Detected cells: 96
- Informative WBCs: 80
- Artefacts/non-WBC detections: 16

| Cell type | Count | % informative WBCs |
|---|---:|---:|
| Neutrophil | 30 | 37.5% |
| Lymphoblast | 24 | 30.0% |
| Myeloblast | 19 | 23.8% |
| Monocyte | 5 | 6.2% |
| Eosinophil | 1 | 1.2% |
| Lymphocyte | 1 | 1.2% |

## Agentic Diagnosis
Predicted diagnosis: **AML** (confidence 0.76). Rationale: learned classifier prediction from detection-derived features.

## Cell Grounding

- `img000_c000` in `34_10_1000_AML.png` bbox=[208.0, 204.5, 275.0, 299.5]: Myeloblast (0.93); nuclear chromatin; nuclear shape; nucleus; cytoplasm.
- `img000_c001` in `34_10_1000_AML.png` bbox=[378.0, 387.0, 450.0, 500.0]: Neutrophil (0.93); nuclear chromatin; nuclear shape; nucleus; cytoplasm.
- `img001_c000` in `34_11_1000_AML.png` bbox=[423.0, 228.75, 506.0, 369.75]: Neutrophil (0.94); nuclear chromatin; nuclear shape; nucleus; cytoplasm.
- `img002_c000` in `34_12_1000_AML.png` bbox=[303.0, 339.5, 372.0, 466.5]: Lymphoblast (0.90); nuclear chromatin; nuclear shape; nucleus; cytoplasm.
- `img003_c000` in `34_13_1000_AML.png` bbox=[48.81, 284.5, 119.56, 413.5]: Neutrophil (0.93); nuclear chromatin; nuclear shape; nucleus; cytoplasm.
- `img004_c000` in `34_14_1000_AML.png` bbox=[561.5, 512.0, 625.5, 615.0]: Monocyte (0.62); nuclear chromatin; nuclear shape; nucleus; cytoplasm.
- `img005_c000` in `34_16_1000_AML.png` bbox=[334.5, 447.5, 406.5, 562.5]: Lymphoblast (0.88); nuclear chromatin; nuclear shape; nucleus; cytoplasm.
- `img005_c001` in `34_16_1000_AML.png` bbox=[313.25, 206.25, 374.75, 319.75]: Myeloblast (0.84); nuclear chromatin; nuclear shape; nucleus; cytoplasm.

> **⚠ Flagged for mandatory human review by the reflection agent.** Reason(s): High blast burden (53.8%) with low classifier confidence (0.76) and significant non-WBC detections (16.7%) suggest borderline diagnostic reliability.
